The Acheivement’s of Proove Bio

News and Media

A medical test that aims to wean America off painkillers

The headlines about Prince's reported painkiller addiction have captured the nation's attention, but the stats on America's opioid crisis show that it's in no way surprising. Opioid addiction claimed 28,000 deaths in 2014, half from painkiller prescriptions, the...

Genetic Test Can Help Prevent America’s Opioid Painkiller Addiction | The Pulse | CNBC

CNBC Published on Sep 7, 2016 Proove Biosciences has developed a series of medical tests that can show a doctor who is at a high risk for developing addiction to opioid painkillers. » Subscribe to CNBC: http://cnb.cx/SubscribeCNBC About CNBC: From 'Wall...

News Conference at APPM Regarding Presidential Candidates, Doctors, and Opioid Abuse

PRConsultant Published on Feb 19, 2016 With prescription drug and heroin overdoses now killing more Americans than car accidents, the opioid crisis has worked its way into the speeches of presidential candidates and a billion dollar plan by President...

October 24, 2013 – Proove Release: Proove Sponsors National Take Back Day

Proove Biosciences Announces Sponsorship of National Drug Take Back Day and HC DrugFree IRVINE, CA (PRWEB) October 24, 2013 Proove Biosciences, the leader in personalized pain medication innovation, is proud to be a Silver Sponsor partner of HC DrugFree and...

April 15, 2014 – Proove Release: Proove Wins Award from American Society of Interventional Pain Physicians for Its Research

Proove Biosciences' Presented Research on the Predictive Risk of Workers Compensation Claims Extending Beyond One Year Irvine, CA (PRWEB) April 15, 2014 Proove Biosciences, the leader in Personalized Pain Medicine testing services, exhibited and presented three...

April 21, 2014 – Issued by the American Academy of Neurology recognizing Proove’s quality research

Low Tolerance for Pain? The Reason May Be In Your Genes Apr 21, 2014, 15:15 ET from American Academy of Neurology ------------------------------------------------------------------------------------------------------- PHILADELPHIA, April 21,...

« Older Entries

July 14, 2015 – Proove Release: Proove Biosciences Presents Research Studies at Neurological Disorders Summit in San Francisco, CA

by admin | February 12, 2018 | In the News | 0 Comments

Irvine, CA (PRWEB) July 14, 2015 Proove Biosciences, a commercial and research leader in Personalized Medicine, recently presented data on three ground-breaking scientific studies at the Neurological Disorders Summit in San Francisco, CA. The Neurological Disorders...

May 31, 2017 – Proove Release: Preliminary Results from Large Clinical Utility Study of Over 27,000 Patients Shows 90% of Patients Experience Significant Pain Reduction From Decisions Made with Proove Technology

by admin | February 12, 2018 | Press Releases | 0 Comments

Preliminary Results of 27,659 patients from MOSAIC Trial Demonstrate that Proove® Technology Leads to Better Patient Outcomes IRVINE, Calif., May 31, 2017 /PRNewswire/ -- Proove® Biosciences, Inc. announces preliminary results at the close of a large patient-centered...

May 5, 2016 – Proove Release: Proove Acquires Algynomics Founded by Leading Researchers in the Field of Pain Genetics

by admin | February 12, 2018 | Press Releases | 0 Comments

Proove Biosciences Closes on the Acquisition of Pain Genetics Firm Algynomics Proove Biosciences, Inc. today announced it has closed on a definitive agreement to acquire Algynomics, a research-stage pain diagnostics company. The Algynomics platform and its patient...

May 10, 2017 – Proove Release: Proove Publishes Another Study Validating 97% Accuracy of Opioid Risk Technology

by admin | February 12, 2018 | Press Releases | 0 Comments

Results Published in the Journal of Addiction Research and Therapy Shows Nearly 97% Accuracy in Identifying Patients At-Risk of Prescription Opioid Abuse IRVINE, Calif., May 10, 2017 /PRNewswire/ -- Proove® Biosciences, Inc. announces a new study validating the...

June 21, 2017 – Proove Release: Large Published Peer-Reviewed Clinical Utility Study Shows Pain Reduction

by admin | February 12, 2018 | Press Releases | 0 Comments

Study Shows Over 90% of Patients Experienced Significant Pain Reduction without Opioid Abuse and Physicians Believe Technology Provides Patient Benefits to Help Reduce Opioid Epidemic IRVINE, Calif., June 21, 2017 /PRNewswire/ -- Proove® Biosciences,...

April 13, 2016 – Proove Release: Proove and Insurer Specialty Health Announce Positive Coverage Determination for Genetic Testing

by admin | February 12, 2018 | In the News | 0 Comments

IRVINE, CA and RENO, NV (PRWEB) April 13, 2016 Proove Biosciences and Specialty Health are excited to announce a positive policy decision on the use of Proove Genetic testing to achieve the quadruple aim of improving outcomes, reducing costs, improving patient care,...

August 2, 2017 | Proove Release: 7 th Published Peer-Reviewed Study in Last 7 Months Supports Proove Technology to Predict Opioid Abuse

by admin | February 12, 2018 | Press Releases | 0 Comments

New Peer-Reviewed Prospective Study Shows that Proove Opioid Risk® Profile Results in Better Pain Management Decisions Providing a 50% Reduction in Pain IRVINE, Calif., Aug. 2, 2017 /PRNewswire/ -- Proove® Biosciences, Inc. announces yet another new...

October 23, 2015 – Proove Release: Proove Partners with USC to Conduct Research

by admin | February 12, 2018 | Press Releases | 0 Comments

Proove Biosciences, a commercial and research leader in personalized medicine, is excited to announce their partnership with the Keck Medicine of the University of Southern California(USC) Pain Center to study the genetics of chronic pain. The T.R.O.J.A.N. Study...

April 25, 2017 – Proove Release: Milestone of the World’s Largest Biobank and Big Data Set in Chronic Pain –

by admin | February 12, 2018 | Press Releases | 0 Comments

Proove® Announces Huge Milestone for its Proove Nexus™ Big Data Platform Commemorating National DNA Day IRVINE, Calif., April 25, 2017 /PRNewswire/ -- Proove® Biosciences, Inc. announces that its Proove Nexus™ platform is the World's Largest DNA Pain Biobank and Big...

April 7, 2015 – Proove Release: Proove Launches Opioid Response Test

by admin | February 12, 2018 | Press Releases | 0 Comments

(PRWEB) APRIL 07, 2015 Proove Biosciences a commercial and research leader in Personalized Medicine, is excited to announce the launch of Proove Opioid Response - the world’s first clinical laboratory test to predict responders to opioid pain medications. Building on...

Get Instant Access to Updates to The Truth about Proove Bio

Success!

Last Name

The Acheivement’s of Proove Bio

News and Media

A medical test that aims to wean America off painkillers

Genetic Test Can Help Prevent America’s Opioid Painkiller Addiction | The Pulse | CNBC

News Conference at APPM Regarding Presidential Candidates, Doctors, and Opioid Abuse

October 24, 2013 – Proove Release: Proove Sponsors National Take Back Day

April 15, 2014 – Proove Release: Proove Wins Award from American Society of Interventional Pain Physicians for Its Research

April 21, 2014 – Issued by the American Academy of Neurology recognizing Proove’s quality research

July 14, 2015 – Proove Release: Proove Biosciences Presents Research Studies at Neurological Disorders Summit in San Francisco, CA

May 31, 2017 – Proove Release: Preliminary Results from Large Clinical Utility Study of Over 27,000 Patients Shows 90% of Patients Experience Significant Pain Reduction From Decisions Made with Proove Technology

May 5, 2016 – Proove Release: Proove Acquires Algynomics Founded by Leading Researchers in the Field of Pain Genetics

May 10, 2017 – Proove Release: Proove Publishes Another Study Validating 97% Accuracy of Opioid Risk Technology

June 21, 2017 – Proove Release: Large Published Peer-Reviewed Clinical Utility Study Shows Pain Reduction

April 13, 2016 – Proove Release: Proove and Insurer Specialty Health Announce Positive Coverage Determination for Genetic Testing

August 2, 2017 | Proove Release: 7 th Published Peer-Reviewed Study in Last 7 Months Supports Proove Technology to Predict Opioid Abuse

October 23, 2015 – Proove Release: Proove Partners with USC to Conduct Research

April 25, 2017 – Proove Release: Milestone of the World’s Largest Biobank and Big Data Set in Chronic Pain –

April 7, 2015 – Proove Release: Proove Launches Opioid Response Test

Video’s

A medical test that aims to wean America off painkillers

Genetic Test Can Help Prevent America’s Opioid Painkiller Addiction | The Pulse | CNBC

News Conference at APPM Regarding Presidential Candidates, Doctors, and Opioid Abuse

OC Tech Alliance High Tech Innovation Awards 2015

SmartCEO Magazine Corporate Culture Awards in 2015

2016 Baltimore Future 50 Awards – Group 5

Get Instant Access to Updates to The Truth about Proove Bio

Success!